ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "outcomes"

  • Abstract Number: 038 • 2020 Pediatric Rheumatology Symposium

    Change in Treatments and Outcomes After Implementation of a National Diagnosis and Treatment Guarantee Program for Juvenile Idiopathic Arthritis in Chile

    Sara Concha1, Pamela Morales 2, Eduardo Talesnik 1 and Arturo Borzutzky 1, 1Department of Infectious Diseases and Pediatric Immunology, School of Medicine, Pontificia Universidad Católica de Chile., Santiago, Chile, 2Department of Pediatric, Clinica Las Condes, Santiago, Chile

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is currently the most common childhood chronic rheumatic disease with high burden and socioeconomic costs for the patient’s family and…
  • Abstract Number: 067 • 2020 Pediatric Rheumatology Symposium

    Response to Treatment with Intra-articular Triamcinolone Hexacetonide and Triamcinolone Acetonide in Oligo-articular Juvenile Idiopathic Arthritis

    Rana Masoud1, Wajiha Jeelani 2, Barbine Agbor Agbor 3, Teresa Hennon 2, Brian Wrotniak 4 and Rabheh Abdul Aziz 2, 1Department of Pediatrics, University at Buffalo, Oishei Children's Hospital, Buffalo, New York, 2Department of Pediatric Rheumatology, University at Buffalo, Oishei Children's Hospital, Buffalo, 3Department of Microbiology and Immunology, Jacobs School of Medicine and Biomedical Sciences, Buffalo, 4Department of Pediatrics, University at Buffalo, Oishei Children's Hospital, Buffalo, NY, USA, Buffalo

    Background/Purpose: Oligo-articular juvenile idiopathic arthritis (Oligo JIA) is the most common subtype of juvenile idiopathic arthritis. Intra-articular corticosteroid (IAC) injection is a mainstay treatment of…
  • Abstract Number: 105 • 2020 Pediatric Rheumatology Symposium

    Discovering the Implications of Adiposity in Juvenile Dermatomyositis

    Vy Do1, Chanhee Jo 2, Jaclyn Albin 1, Tracey Wright 1, Julie Fuller 3 and Una Makris 1, 1UT Southwestern Medical Center, Dallas, 2Texas Scottish Rite Hospital, Dallas, 3UT Southwestern Medical Center, Frisco

    Background/Purpose: Obesity and pro-inflammatory cytokines produced by adipocytes have been linked to many outcomes including disease severity, treatment response, and disease progression in several autoimmune…
  • Abstract Number: 109 • 2020 Pediatric Rheumatology Symposium

    Incidence, Contributing Factors, and Impact of Diagnostic Delay in Juvenile Idiopathic Arthritis: Analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry

    Mei-Sing Ong1, Gordon Schiff 2 and Marc Natter 3 for the CARRA investigators, 1Harvard Medical School & Harvard Pilgrim Healthcare Institute, Boston, 2Harvard Medical School, Boston, 3Boston Children's Hospital, Boston

    Background/Purpose: While early treatment of patients with newly diagnosed juvenile idiopathic arthritis (JIA) is an area of active study, delayed diagnosis of JIA is poorly…
  • Abstract Number: 118 • 2020 Pediatric Rheumatology Symposium

    Long-Term Outcomes in Children Born to Anti-Ro and/or anti-La Positive Mothers

    Talia Diaz1, Daniela Dominguez 2, Andrea Knight 3, Carl A. Laskin 4, Lawrence Ng 2, Franklin Silverio 2, Earl D. Silverman 5 and Linda Hiraki 6, 1Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada, 2Division of Rheumatology, The Hospital for Sick Children, Toronto, Canada, 3SickKids Research Institute, Toronto, Canada, 4Mount Sinai Hospital and University of Toronto, Toronto, Canada, 5Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Canada, 6Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Canada

    Background/Purpose: Neonatal Lupus Erythematosus (NLE) is an acquired autoimmune disorder associated with the transplacental passage of maternal anti-Ro and/or anti-La antibodies. NLE manifestations include cardiac,…
  • Abstract Number: 125 • 2020 Pediatric Rheumatology Symposium

    Feasibility and Pilot Study of Mental Health Screening in Juvenile Myositis

    Kaveh Ardalan1, Alison Manning 1, Brian Feldman 2, Gary Maslow 1 and Andrea Knight 3, 1Duke University Medical Center, Durham, 2The Hospital for Sick Children, Toronto, Canada, 3SickKids Research Institute, Toronto, Canada

    Background/Purpose: Juvenile myositis (JM) negatively affects health-related quality of life due to chronic weakness, skin/muscle damage, multiorgan dysfunction, and side effects of immunosuppression. While JM’s…
  • Abstract Number: 133 • 2020 Pediatric Rheumatology Symposium

    Pediatric Rheumatology Consultation for Both Traditional and Emerging Rheumatic Diseases in the Critical Care Setting

    Jennifer Rammel1, Kristen Staggers 2, Satid Thammasitboon 2, Jorge Coss Bu 2, Amanda Brown 3 and Eyal Muscal 4, 1Section of Nephrology and Rheumatology, Department of Pediatrics, University of Florida Health Jacksonville, Jacksonville, Florida, 2Baylor College of Medicine, Houston, Texas, 3Baylor College of Medicine, Houston, 4Section of Rheumatology, Department of Pediatrics, Baylor College of Medicine, houston

    Background/Purpose: In addition to traditional rheumatic diseases (TRDs), Pediatric Rheumatologists are often consulted on emerging rheumatic diseases (ERDs) such as autoimmune encephalitis, seronegative vasculitides, and…
  • Abstract Number: 175 • 2020 Pediatric Rheumatology Symposium

    Application of Juvenile Idiopathic Arthritis Treatment Guidelines and Factors Associated with Increased Likelihood of Intra-articular Corticosteroid Administration

    Erin Balay1, Jennifer Weiss 2, Y. Ingrid Goh 3, Nathan Rubin 4 and Danielle Bullock 4, 1University of Minnesota, saint paul, 2Hackensack University Medical Center, Hackensack, 3The Hospital for Sick Children, Toronto, Canada, 4University of Minnesota, Minneapolis

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is a chronic childhood disease which can result in debilitating arthritis. The 2011 ACR JIA treatment guidelines recommend intra-articular corticosteroid…
  • Abstract Number: 177 • 2020 Pediatric Rheumatology Symposium

    Educational Outcomes in a Young-Adult Cohort of Patients with Childhood Onset Systemic Lupus Erythematosus (SLE)

    Anita Dhanrajani1, Earl D. Silverman 2, Andrea Knight 3, Deborah Levy 4 and Amanda Steiman 5, 1Hospital for Sick Kids, Edmonton, Alberta, Canada, 2Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Canada, 3SickKids Research Institute, Toronto, Canada, 4Division of Rheumatology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Canada, 5Sinai Health System, Toronto, Ontario, Canada

    Background/Purpose: The literature regarding educational and socioeconomic outcomes in young adults with childhood-onset Systemic Lupus Erythematosus (cSLE) are sparse. cSLE patients recently transitioned to adult…
  • Abstract Number: 2628 • 2019 ACR/ARP Annual Meeting

    Mortality Predictors in ANCA-associated Vasculitis: Experience of a Brazilian Monocentric Cohort of a Rheumatology Center

    Marilia Dagostin1, Sergio Nunes 2, Samuel Shinjo 3 and Rosa Pereira 4, 1University of Sao Paulo, São Paulo, Brazil, 2Univeristy Of Sao Paulo, São Paulo, 3Univeristy Of Sao Paulo, São Paulo, Brazil, 4Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Sao Paulo, Brazil

    Background/Purpose: Mortality of patients with ANCA-associated vasculitis (AAV) is higher than the general population. There are few papers in the literature regarding the factors associated…
  • Abstract Number: 2872 • 2019 ACR/ARP Annual Meeting

    Risk of 30-day Readmission and Adverse Events After Primary Hip or Knee Arthroplasty: A Comparison of Patients with Rheumatoid Arthritis versus Osteoarthritis Using the Nationwide Readmission Database

    Ali Yazdanyar1, Anthony Donato 2, Kathleen McElwee 3, Mary Chester Wasko 4 and Michael Ward 5, 1Lehigh Valley Hospital- Cedar Crest, Allentown, PA, 2Reading Hospital, PA, Reading, 3Reading Hospital, Reading, PA, 4Allegheny Health Network-West Penn Hospital, Pittsburgh, PA, 5NIAMS, Bethesda, MD

    Background/Purpose: To assess the risk of 30-day readmission, mortality, and adverse events among adults with Rheumatoid Arthritis as compared to Osteoarthritis after primary hip or…
  • Abstract Number: 333 • 2019 ACR/ARP Annual Meeting

    Assessing the Relationship Between Gout and Return to Hemodialysis Among U.S. Renal Transplant Patients

    Justin Li1, David Yin 1, Zheng Wang 1, Mark Brigham 1, Brian LaMoreaux 2, Jeffrey Kent 2, Megan Francis-Sedlak 2, Richard Johnson 3, Nandini Hadker 1 and Gavin Miyasato 1, 1Trinity Partners, Waltham, MA, 2Horizon Therapeutics plc, Lake Forest, IL, 3University of Colorado Denver, Aurora, CO

    Background/Purpose: Although gout has been shown to be associated with poor renal outcomes among chronic kidney disease populations, this relationship is not well understood among…
  • Abstract Number: 869 • 2019 ACR/ARP Annual Meeting

    Clinical Manifestations of Patients with Eosinophilic Granulomatosis with Polyangiitis in a Large North American Cohort

    Irena Doubelt1, David Cuthbertson 2, Simon Carette 1, Nader A. Khalidi 3, Curry L. Koening 4, Carol Langford 5, Carol A. McAlear 6, Larry W. Moreland 7, Paul Monach 8, Philip Seo 9, Ulrich Specks 10, Antoine Sreih 11, Steven Ytterberg 10, Peter A. Merkel 12, Christian Pagnoux 1 and VCRC Vasculitis Clinical Research Consortium 13, 1Mount Sinai Hospital and University Health Network, Toronto, ON, Canada, 2University of South Florida, Tampa, FL, 3McMaster University, Hamilton, ON, Canada, 4University of Utah Hospital, Salt Lake City, UT, 5Cleveland Clinic, Cleveland, OH, 6University of Pennsylvania - VCRC Project Manager, Philadelphia, PA, 7University of Pittsburgh, Pittsburgh, PA, 8Brigham and Women's Hospital, Boston, MA, 9Johns Hopkins Medicine, Baltimore, MD, 10Mayo Clinic College of Medicine, Rochester, MN, 11University of Pennsylvania, Philadelphia, PA, 12Univeristy of Pennsylvania, Philadelphia, PA, 13University of Pennsylvania, Division of Rheumatology, philadelphia

    Background/Purpose: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, systemic necrotizing small-vessel vasculitis, with only a few published North American series. This project aimed to…
  • Abstract Number: 604 • 2018 ACR/ARHP Annual Meeting

    Combining Observational and Randomized Controlled Trial Data Evidence to Jointly Estimate Remission and Response for Biologic and Non-Biologic Therapies in Rheumatoid Arthritis: A Bivariate Network Meta-Analysis

    Gyanendra Pokharel1, Rob Deardon1, Cheryl Barnabe2, Vivian P. Bykerk3, Susan J. Bartlett4, Louis Bessette5, Gilles Boire6, Carol Hitchon7, Edward C. Keystone8, Janet E. Pope9, Diane Tin10, Carter Thorne11 and Glen Hazlewood12, 1Department of Mathematics and Statistics, University of Calgary, Calgary, AB, Canada, 2Medicine, University of Calgary, Calgary, AB, Canada, 3Hospital for Special Surgery, New York, NY, 4Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 5Division of Rheumatology, Department of Medicine, CHU de Québec-Université Laval, Québec, QC, Canada, 6Rheumatology Division, Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke and Universite de Sherbrooke, Sherbrooke, QC, Canada, 7University of Manitoba, Winnipeg, MB, Canada, 8Mount Sinai Hospital, Toronto, ON, Canada, 9Department of Medicine, University of Western Ontario, London, ON, Canada, 10The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 11University of Toronto, Newmarket, ON, Canada, 12Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Remission is the goal of rheumatoid arthritis (RA) treatment, but ACR responses are more commonly measured in clinical trials. As such, data on remission…
  • Abstract Number: 2406 • 2018 ACR/ARHP Annual Meeting

    Clinical Presentation, Management and Long Term Outcome of Pars Planitis (PP), Panuveitis (PU) and Vogt–Koyanagi–Harada Disease (VKH) in Children and Adolescents

    Andreas Reiff, Children’s Hospital of Los Angeles, Los Angeles, CA

    Background/Purpose: Chronic uveitis is a common manifestation of pediatric rheumatologic conditions and may result in irreversible blindness and long term disability. While chronic anterior uveitis…
  • 1
  • 2
  • 3
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.